Document is current

Article History

Received: 10 March 2023

Accepted: 1 August 2023

First Online: 23 August 2023

Declarations

:

: The study was approved and overseen by Naval Medical Research Unit No. 6 Institutional Review Board (IRB) in Peru (NAMRU6.2014.0028) and by central SUNY Upstate IRB (417710) and Luis Vernaza Hospital (HLV-CEISH-2020-005) in Ecuador, in compliance with all applicable federal regulations governing the protection of human subjects. All participants provided written informed consent and/or assent (for children aged 8 years and above only) prior to study-related activities.

: Dissemination of findings including via publication was included in the consent form signed by participants.

: Amy M. Jones, Charlotte Panter, Frances White, Verity Smith, Helen Kendal and Adam Gater are employees of Adelphi Values Ltd, a health outcome agency, who were paid by the study sponsor (Merck Sharpe & Dohme) to conduct the research described in this manuscript and write this manuscript. Jane R. Wells was an employee of Adelphi Values Ltd at the time of research and is now employed by Sanofi. Todd L. Saretsky, Kevin Russell, Madelyn Ruggieri, Shawna R, Calhoun and Justin O’Hagan are employees of Merck Sharpe & Dohme, the study sponsor. Morgan A. Marks was an employee of Merck Sharpe & Dohme at the time of research and is now employed by Moderna Inc. Kathryn B. Anderson, Lisa Ware, Michelle Klick and Stephen Thomas are employees of State University of New York and were involved in the running of the Dengue Human Infection Model where the DENV-DD was implemented. Kathryn B. Anderson was also involved in the recruitment of dengue participants from the Ecuador site. Valarie A. Paz-Soldan is an employee of Tulane School of Public Health and Tropical Medicine and Amy C. Morrison is an employee of the University of California, Davis and were both involved in the recruitment of dengue participants from the Peru site.